MedDataX Logo

Impact of Perioperative Allogeneic Red Blood Cell Transfusion on Postoperative Myocardial Injury After Liver Resection

NCT ID: NCT07125612

Last Updated: 2025-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

487 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-01

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We aimed to explore the influence of ABT on the incidence of MINS, AKI, and overall prognosis among advanced-age HCC patients who underwent hepatectomy

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Anemia and Surgery: Indications For Transfusion

NCT00005308

Blood Disease Anemia
COMPLETED

Advance Targeted Transfusion in Anemic Cardiac Surgical Patients for Kidney Protection: A Proof of Concept Pilot Study

NCT00861822

Kidney Injury
COMPLETED PHASE1

The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery

NCT06109155

Surgery, Cardiac Tranxemic Acid Activated Clotting Time +2 more
RECRUITING PHASE4

Acetaminophen and AKI After Aortic Surgery

NCT04882202

Aortic Surgery
RECRUITING NA

Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery

NCT00651573

Anemia
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Injury Acuter Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients over 65 years with HCC undergoing elective surgery between January 2016 and December 2018

Exclusion Criteria

ASA grade V requiring repeat surgery within 1 week losing to follow-up and/or those with \>5% missing data
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hao Li

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hao Li

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ChinaPLAGH_transfusion

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection
NCT01651182 COMPLETED PHASE3
Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery
NCT04911413 COMPLETED PHASE4
Impact of RBC Transfusion Less Than 14 Days on Morbidity and Mortality in Cardiac Surgical Patients
NCT01915654 TERMINATED
Coagulopathy in Cardiac Surgery
NCT03475940 COMPLETED
ABC - A Post Intensive Care Anaemia Management Trial
NCT04591574 ACTIVE_NOT_RECRUITING NA
Intraoperative Phlebotomies and Bleeding in Liver Transplantation
NCT04826666 COMPLETED
The Effect of Tranexamic Acid on Postoperative Blood Loss and Coagulation in Patients With Preoperative Anemia Undergoing Off-Pump Coronary Artery Bypass Graft; Double Blind Randomized Control Study
NCT01067638 COMPLETED PHASE4
Packed Red Blood Cell Transfusion in Elective Coronary Artery Bypass Graft Surgery in A University Hospital
NCT02585310 COMPLETED
Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery
NCT00516126 COMPLETED
The Effects of Tranexamic Acid or Placebo on Perioperative Bleeding in Adults Undergoing Liver Transplantation.
NCT04753151 UNKNOWN NA
Acute Normovolemic Hemodilution in Complex Cardiac Surgery
NCT05049590 COMPLETED PHASE3
Impact of Acute Normovolemic Hemodilution on Blood Viscosity
NCT03366753 COMPLETED NA
A Randomized Comparison of Two Doses of Tranexamic Acid in Open-Heart Surgery
NCT04996368 COMPLETED NA
Red Cell Storage Duration and Outcomes in Cardiac Surgery
NCT00458783 COMPLETED NA
Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery
NCT00825981 COMPLETED
Reducing Post Operative Bleeding Following Cabg
NCT01600599 COMPLETED NA
Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery
NCT06509256 NOT_YET_RECRUITING EARLY_PHASE1
Early Whole Blood in Patients Requiring Transfusion After Major Trauma
NCT01227005 COMPLETED PHASE4
Hemostatic Effects of Ulinastatin and Tranexamic Acid in Cardiac Surgery
NCT01060189 COMPLETED NA
Haemostasis Management of Abdominal Aortic Procedures
NCT03426839 UNKNOWN NA
Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery
NCT02277379 COMPLETED
Adverse Effects of Red Blood Cell Transfusions: A Unifying Hypothesis (Aim 3)
NCT02280655 COMPLETED PHASE2
Machine Learning-Based Prediction of Major Perioperative Allogeneic Blood Requirements in Cardiac Surgery
NCT04856618 COMPLETED
Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy
NCT05816668 UNKNOWN PHASE3
Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy
NCT00200148 COMPLETED PHASE3